UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 191

Sortiert nach

Time inside the mutant selection window as a predictor of staphylococcal resistance to linezolid

Journal of antibiotics, 2018-05, Vol.71 (5), p.514-521

2018

Link zum Volltext

Verfügbarkeit prüfen

Fluorescence Microscopy: Determination of Meropenem Activity against Klebsiella pneumoniae

Antibiotics (Basel), 2023-07, Vol.12 (7), p.1170

2023

Link zum Volltext

Verfügbarkeit prüfen

Predicting the antistaphylococcal effects of daptomycin-rifampicin combinations in an in vitro dynamic model

Journal of antibiotics, 2020-02, Vol.73 (2), p.101-107

2020

Link zum Volltext

Verfügbarkeit prüfen

Profile of a Novel Anionic Fluoroquinolone-Delafloxacin

Clinical infectious diseases, 2019-04, Vol.68 (Supplement_3), p.S213-S222

2019

Link zum Volltext

Verfügbarkeit prüfen

Pharmacodynamics of Doripenem Alone and in Combination with Relebactam in an In Vitro Hollow-Fiber Dynamic Model: Emergence of Resistance of Carbapenemase-Producing Klebsiella pneumoniae and the Inoculum Effect

Antibiotics (Basel), 2023-12, Vol.12 (12), p.1705

2023

Link zum Volltext

Verfügbarkeit prüfen

Comparative Meropenem Pharmacodynamics and Emergence of Resistance against Carbapenem-Susceptible Non-Carbapenemase-Producing and Carbapenemase-Producing Enterobacterales: A Pharmacodynamic Study in a Hollow-Fiber Infection Model

Antibiotics (Basel), 2023-12, Vol.12 (12), p.1717

2023

Link zum Volltext

Verfügbarkeit prüfen

Meropenem MICs at Standard and High Inocula and Mutant Prevention Concentration Inter-Relations: Comparative Study with Non-Carbapenemase-Producing and OXA-48-, KPC- and NDM-Producing Klebsiella pneumoniae

Antibiotics (Basel), 2023-05, Vol.12 (5), p.872

2023

Link zum Volltext

Verfügbarkeit prüfen

Bacterial Resistance Studies Using In Vitro Dynamic Models: the Predictive Power of the Mutant Prevention and Minimum Inhibitory Antibiotic Concentrations

Antimicrobial Agents and Chemotherapy, 2013-10, Vol.57 (10), p.4956-4962

2013

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Pharmacodynamic Evaluation of the Mutant Selection Window Hypothesis Using Four Fluoroquinolones against Staphylococcus aureus

Antimicrobial Agents and Chemotherapy, 2003-05, Vol.47 (5), p.1604-1613

2003

Link zum Volltext

Verfügbarkeit prüfen

Burden of antimicrobial resistance in an era of decreasing susceptibility

Expert review of anti-infective therapy, 2017-07, Vol.15 (7), p.663-676

2017

Link zum Volltext

Verfügbarkeit prüfen

Predicting the Effects of Carbapenem/Carbapenemase Inhibitor Combinations against KPC-Producing Klebsiella pneumoniae in Time-Kill Experiments: Alternative versus Traditional Approaches to MIC Determination

Antibiotics (Basel), 2021-12, Vol.10 (12), p.1520

2021

Link zum Volltext

Verfügbarkeit prüfen

Klebsiella pneumoniae Susceptibility to Carbapenem/Relebactam Combinations: Influence of Inoculum Density and Carbapenem-to-Inhibitor Concentration Ratio

Biomedicines, 2022-06, Vol.10 (6), p.1454

2022

Link zum Volltext

Verfügbarkeit prüfen

MPC-Based Prediction of Anti-Mutant Effectiveness of Antibiotic Combinations: In Vitro Model Study with Daptomycin and Gentamicin against Staphylococcus aureus

Antibiotics (Basel), 2021-09, Vol.10 (10), p.1148

2021

Link zum Volltext

Verfügbarkeit prüfen

Verification of a Novel Approach to Predicting Effects of Antibiotic Combinations: In Vitro Dynamic Model Study with Daptomycin and Gentamicin against Staphylococcus aureus

Antibiotics (Basel), 2020-09, Vol.9 (9), p.538

2020

Link zum Volltext

Verfügbarkeit prüfen

Comparative Pharmacodynamics and Antimutant Potentials of Doripenem and Imipenem with Ciprofloxacin-Resistant Pseudomonas aeruginosa in an In Vitro Model

Antimicrobial Agents and Chemotherapy, 2012-03, Vol.56 (3), p.1223-1228

2012

Link zum Volltext

Verfügbarkeit prüfen

Antibiotic Development and the Evolving Role of Pharmacodynamics — As Good as It Gets?

EBioMedicine, 2015-07, Vol.2 (7), p.615-616

2015

Link zum Volltext

Verfügbarkeit prüfen

Testing the mutant selection window hypothesis with meropenem: In vitro model study with OXA-48-producing Klebsiella pneumoniae

PloS one, 2023-08, Vol.18 (8), p.e0288660-e0288660

2023

Link zum Volltext

Verfügbarkeit prüfen

Overview of Antibiotic Use and Resistance: Setting the Stage for Tigecycline

Clinical infectious diseases, 2005-09, Vol.41 (Supplement-5), p.S289-S292

Zinner, Stephen H

2005

Link zum Volltext

Verfügbarkeit prüfen

Enrichment of Fluoroquinolone-Resistant Staphylococcus aureus: Oscillating Ciprofloxacin Concentrations Simulated at the Upper and Lower Portions of the Mutant Selection Window

Antimicrobial Agents and Chemotherapy, 2008-06, Vol.52 (6), p.1924-1928

2008

Link zum Volltext

Verfügbarkeit prüfen

Anti-mutant efficacy of antibiotic combinations: in vitro model studies with linezolid and daptomycin

Journal of antimicrobial chemotherapy, 2021-07, Vol.76 (7), p.1832-1839

2021

Link zum Volltext

Verfügbarkeit prüfen

Predictors of bacterial resistance using in vitro dynamic models: area under the concentration-time curve related to either the minimum inhibitory or mutant prevention antibiotic concentration

Journal of antimicrobial chemotherapy, 2016-03, Vol.71 (3), p.678-684

2016

Link zum Volltext

Verfügbarkeit prüfen

Predicting antibiotic combination effects on the selection of resistant Staphylococcus aureus: In vitro model studies with linezolid and gentamicin

International journal of antimicrobial agents, 2018-12, Vol.52 (6), p.854-860

2018

Link zum Volltext

Verfügbarkeit prüfen

Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to linezolid in an in vitro dynamic model

Journal of antimicrobial chemotherapy, 2017-11, Vol.72 (11), p.3100-3107

2017

Link zum Volltext

Verfügbarkeit prüfen

Searching for the Optimal Predictor of Ciprofloxacin Resistance in Klebsiella pneumoniae by Using In Vitro Dynamic Models

Antimicrobial agents and chemotherapy, 2016-03, Vol.60 (3), p.1208-1215

2016

Link zum Volltext

Verfügbarkeit prüfen

Antistaphylococcal Effect Related to the Area under the Curve/MIC Ratio in an In Vitro Dynamic Model: Predicted Breakpoints versus Clinically Achievable Values for Seven Fluoroquinolones

Antimicrobial Agents and Chemotherapy, 2005-07, Vol.49 (7), p.2642-2647

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 191

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(175)
Mit Volltextzugriff
(160)

Publikationsform

Sprache

Englisch
(185)
Russisch
(33)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(122)
Life Sciences & Biomedicine
(121)
Humans
(87)
Microbiology
(74)
Pharmacology & Pharmacy
(73)
Infectious Diseases
(66)
Microbial Sensitivity Tests
(42)
Area Under Curve
(35)
Anti-Bacterial Agents - Pharmacology
(33)
Fluoroquinolones
(33)
Biological And Medical Sciences
(30)
Models, Biological
(29)
Staphylococcus Aureus
(29)
Antibiotics
(28)
Medical Sciences
(28)
Female
(27)
Staphylococcus Aureus - Drug Effects
(27)
Ciprofloxacin - Pharmacology
(24)
Anti-Infective Agents - Pharmacology
(21)
Infections
(20)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Time inside the mutant selection window as a predictor of staphylococcal resistance to linezolid

Fluorescence Microscopy: Determination of Meropenem Activity against Klebsiella pneumoniae

Predicting the antistaphylococcal effects of daptomycin-rifampicin combinations in an in vitro dynamic model

Profile of a Novel Anionic Fluoroquinolone-Delafloxacin

Pharmacodynamics of Doripenem Alone and in Combination with Relebactam in an In Vitro Hollow-Fiber Dynamic Model: Emergence of Resistance of Carbapenemase-Producing Klebsiella pneumoniae and the Inoculum Effect

Comparative Meropenem Pharmacodynamics and Emergence of Resistance against Carbapenem-Susceptible Non-Carbapenemase-Producing and Carbapenemase-Producing Enterobacterales: A Pharmacodynamic Study in a Hollow-Fiber Infection Model

Meropenem MICs at Standard and High Inocula and Mutant Prevention Concentration Inter-Relations: Comparative Study with Non-Carbapenemase-Producing and OXA-48-, KPC- and NDM-Producing Klebsiella pneumoniae

Bacterial Resistance Studies Using In Vitro Dynamic Models: the Predictive Power of the Mutant Prevention and Minimum Inhibitory Antibiotic Concentrations

In Vitro Pharmacodynamic Evaluation of the Mutant Selection Window Hypothesis Using Four Fluoroquinolones against Staphylococcus aureus

Burden of antimicrobial resistance in an era of decreasing susceptibility

Predicting the Effects of Carbapenem/Carbapenemase Inhibitor Combinations against KPC-Producing Klebsiella pneumoniae in Time-Kill Experiments: Alternative versus Traditional Approaches to MIC Determination

Klebsiella pneumoniae Susceptibility to Carbapenem/Relebactam Combinations: Influence of Inoculum Density and Carbapenem-to-Inhibitor Concentration Ratio

MPC-Based Prediction of Anti-Mutant Effectiveness of Antibiotic Combinations: In Vitro Model Study with Daptomycin and Gentamicin against Staphylococcus aureus

Verification of a Novel Approach to Predicting Effects of Antibiotic Combinations: In Vitro Dynamic Model Study with Daptomycin and Gentamicin against Staphylococcus aureus

Comparative Pharmacodynamics and Antimutant Potentials of Doripenem and Imipenem with Ciprofloxacin-Resistant Pseudomonas aeruginosa in an In Vitro Model

Antibiotic Development and the Evolving Role of Pharmacodynamics — As Good as It Gets?

Testing the mutant selection window hypothesis with meropenem: In vitro model study with OXA-48-producing Klebsiella pneumoniae

Overview of Antibiotic Use and Resistance: Setting the Stage for Tigecycline

Enrichment of Fluoroquinolone-Resistant Staphylococcus aureus: Oscillating Ciprofloxacin Concentrations Simulated at the Upper and Lower Portions of the Mutant Selection Window

Anti-mutant efficacy of antibiotic combinations: in vitro model studies with linezolid and daptomycin

Predictors of bacterial resistance using in vitro dynamic models: area under the concentration-time curve related to either the minimum inhibitory or mutant prevention antibiotic concentration

Predicting antibiotic combination effects on the selection of resistant Staphylococcus aureus: In vitro model studies with linezolid and gentamicin

Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to linezolid in an in vitro dynamic model

Searching for the Optimal Predictor of Ciprofloxacin Resistance in Klebsiella pneumoniae by Using In Vitro Dynamic Models

Antistaphylococcal Effect Related to the Area under the Curve/MIC Ratio in an In Vitro Dynamic Model: Predicted Breakpoints versus Clinically Achievable Values for Seven Fluoroquinolones

Suchergebnisse filtern